Primary Care
Physician perspectives on preventive care, chronic disease management, and evidence-based primary care practice.
Recent Discussions
Do you ever recommend the use of a Creatine Monohydrate supplementation to your patients looking to improve physical fitness?
Yes. I do recommend Creatine Monohydrate for patients/athletes hoping to gain strength and muscle mass. The current data is favorable for short bursts of strength or speed, but there is some growing evidence that there may be some benefit for higher rep/longer exertion and possibly for cognitive hea...
How do you counsel patients struggling to decide if they wish to pursue an invasive diagnostic procedure to confirm a severe illness with poor prognosis and/or limited treatment options?
First, I would reassure them that there is no right answer to this question. What we're trying to do is to come up with an answer that the patient can be psychologically at peace with. Second, I would begin to inquire about what we will do with the information, or, to put it differently, how the inf...
How do you counsel patients struggling to decide if they wish to pursue an invasive diagnostic procedure to confirm a severe illness with poor prognosis and/or limited treatment options?
First, I would reassure them that there is no right answer to this question. What we're trying to do is to come up with an answer that the patient can be psychologically at peace with. Second, I would begin to inquire about what we will do with the information, or, to put it differently, how the inf...
What ways can POCUS assist in volume status assessments in the clinic for patients who are unable to lie at an incline or get onto the exam table?
Good question. POCUS would assist with my assessment in a few ways (interpretation and application depend on comorbidities and pretest probabilities of certain pathologies). In someone with mobility issues, you can use POCUS to find the jugular vein meniscus and assist with JVP assessment. Additiona...
What therapies have you found most effective for managing patients with Darier disease?
Because of the amazing bench-to-bedside paper below, my most severe Darier's patient started on an IL17 inhibitor, and it is the closest thing I've seen to a miracle in ages. She was refractory to everything we tried, and is now 80+% clear. What a joy to see science change people's lives!Ettinger et...
How would you approach the treatment of a patient with solid food esophageal dysphagia and GERD without a detectable esophageal stricture on upper endoscopy?
I would obtain a barium esophagram followed by high-resolution esophageal manometry and 48-hour esophageal pH testing.
Do you adhere to the standard 5-day minimum treatment duration for community-acquired pneumonia, or have you used shorter courses for certain low-risk patients?
This is a question addressing a shorter duration of antibiotic therapy than the current IDSA guidelines for community-acquired pneumonia (CAP) recommend. It has been the topic of several studies, for example, 3-day treatment (Richard T. Ellison III, MD, reviewing Dinh et al., PMID 33773631; Niederma...
How do you counsel patients interested in estrogen containing oral contraceptives who have migraine with aura?
Outside of patients whose attacks are suggestive of hemiplegic migraine, I do not typically avoid the use of estrogen-containing OCPs. While it is my understanding that a number of international organizations and many neurologists (as well as Ob/Gyn) recommend their avoidance, there are several revi...
When home BP readings are consistently lower than office measurements, how do you decide whether to intensify, maintain, or de-escalate antihypertensive therapy?
If the home readings can be confirmed to be appropriately measured (i.e., in a hard-backed chair with arm support and checking multiple repeated readings), then I will adjust BP medications to target the average home BP of <130/80 (going lower toward 120/80, if tolerated). However, I have had patien...
How should clinicians balance the use of finerenone with other heart failure treatments like SGLT2 inhibitors, considering their glycemic benefits?
Finerenone could replace spironolactone or eplerenone since the likelihood of adverse effects are less. Unfortunately, RCTs of finerenone have compared it placebo. Until superiority to spironolactone (a cheap and very effective drug for heart failure) is shown we cannot justify the cost.